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Abstract
Background: It is well known that antidepressants increase neurogenesis in the dentate gyrus of
the hippocampus. The increase of neurogenesis might contribute to the behavioral effects of
antidepressants. However, the mechanism by which antidepressants increase hippocampal
neurogenesis is largely unknown. It has been recently reported that astroglia induce the
neurogenesis of the hippocampal neural progenitor cells (NPCs). Therefore, we hypothesized that
antidepressants may act on astrocytes, and this in turn induces neurogenesis of NPCs.
Results: To examine this hypothesis, we used two co-culture systems, i.e., a contact-independent
Banker culture and a contact-dependent overlay co-culture. In both of these systems, in
comparison with naïve astrocytes, antidepressant-treated astrocytes did not further increase the
proliferation of NPCs.
Conclusion: These results suggest that astrocytes increase the proliferation of hippocampal
NPCs, however, this may not be directly involved in the antidepressant-induced proliferation of
NPCs.
Background
Depressive disorder is a chronic, life-threatening illness
that may be caused by genetic and environmental factors
such as stress [1]. Of all the brain regions related to
depressive disorders, the hippocampus has received the
most attention because many patients suffering from
depressive disorders exhibit atrophy in the hippocampus,
which regulates the stress response by participating in the
hypothalamic-pituitary-adrenal (HPA) axis [2,3].
Recently, it has been reported that antidepressant treat-
ment increases neurogenesis in the dentate gyrus of the
hippocampus, and this increased neurogenesis is required
for the behavioral effects of antidepressants [4,5]. How-
ever, the mechanism by which antidepressants induce
neurogenesis in the hippocampus is largely unknown.
It has been well known that astroglia support the func-
tions of neurons. However, a number of recent studies
have also shown that astroglia actively control many neu-
ronal functions and development; moreover, this is
related to many neurological disorders [6-11]. Many anti-
depressants are serotonin or norepinephrine reuptake
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and a norepinephrine transporter [13,14], and this raises
the possibility that these cells may be activated and play a
role in the action of antidepressants. Moreover, it was
recently reported that astroglia induce neurogenesis by
increasing the proliferation and differentiation of neural
progenitor cells (NPCs) in the dentate gyrus of the hip-
pocampus [15].
We thus hypothesized that when astrocytes are activated
by antidepressants, they may release factors that can
induce neurogenesis in the dentate gyrus of the hippoc-
ampus. In addition, neurogenesis induced by astrocyte-
releasing factors may be involved in the behavioral effects
of antidepressants. To examine our hypothesis, we used
two types of astrocyte-NPC co-culture systems and meas-
ured the proliferation of NPCs by using BrdU immunocy-
tochemical analysis.
Results and Discussion
Before we examined our hypothesis, we identified cul-
tured astrocytes and NPCs by immunocytochemistry. As
shown in Fig 1A, astrocytes were glial fibrillary acidic pro-
tein (GFAP)-positive (astrocyte marker, left panel) and
NPCs were nestin-positive (NPC marker, right panel).
Antidepressants have been shown to induce the expres-
sion of GDNF mRNA [12,16]. To verify the effectiveness
of antidepressants in our culture system, we performed
RT-PCR for the measurement of GDNF mRNA. Astrocytes
were treated with 10 µM of desipramine or fluoxetine.
Upon treatment of astrocytes with fluoxetine or
desipramine for 48 h, the expression level of GDNF
mRNA was higher in cells treated with each antidepres-
sant than that in control cells (Fig. 1B), thereby indicating
that these antidepressants were effective at least in induc-
ing GDNF in the astrocytes.
BrdU is incorporated into the DNA of proliferating NPCs.
Thus, the appearance of BrdU immunoreactivity within a
cell indicates that the cell was undergoing proliferation at
the time upon BrdU was added. Using the BrdU-labeling
method, we examined whether antidepressant-treated
astrocytes could induce the proliferation of hippocampal
NPCs, possibly through diffusible factors. To test this pos-
sibility, we used the Banker culture system, which does
not allow direct contact between astrocytes and NPCs
(Fig. 2A) [17]. The number of BrdU (+) cells was increased
in NPCs co-cultured with naïve astrocytes (Fig. 2B; Con-
trol: 18.1% ± 0.9%, n = 12; naïve: 38.3% ± 4.6%, n = 10;
p < 0.001). This result is consistent with previous findings
[15]. However, in comparison with naïve astrocytes, the
number of BrdU (+) cells was not further increased in
NPCs co-cultured with astrocytes treated with 10 µM of
desipramine or fluoxetine (Fig. 2B; Dep.: 31.2% ± 4.0%, n
= 10; Flx.: 33.1% ± 3.6%, n = 10; p > 0.05, in comparison
with the naïve group). Thus, these results show that the
treatment of astrocytes with desipramine or fluoxetine
may not affect the proliferation of NPCs via diffusible pro-
liferating factors.
On the other hand, the involvement of astrocytes in the
proliferation of NPCs could possibly occur in a contact-
dependent manner [15]. To test this possibility, we used
the overlay co-culture system. In this culture system, astro-
cytes serve as the substrate cells for NPCs that have been
labeled with GFP (Fig. 3A). As shown in Fig. 3B, in com-
parison with naïve astrocytes, those treated with 10 µM of
desipramine or fluoxetine did not increase the number of
BrdU and GFP double-positive cells (naïve: 28.5% ±
1.8%, n = 4; Dep.: 25.6% ± 0.7%, n = 5; Flx.: 23.1% ±
1.6%, n = 5, p > 0.05), indicating that desipramine- or
Cultured hippocampal astrocytes, NPCs and the expression of GDNF mRNA in ntidepressant-treated astrocytesFigure 1
Cultured hippocampal astrocytes, NPCs and the 
expression of GDNF mRNA in antidepressant-
treated astrocytes. (A) Cultured hippocampal astrocytes 
and GFP expressing NPCs were stained with GFAP (left, 
green) and nestin (right, red) antibody, respectively. Astro-
cytes were counterstained with PI (left, red). NPCs were 
stained after the transduction with GFP-expressing retrovi-
rus. Scale bar, 50 µm (left) and 100 µm (right). (B) The 
results show the RT-PCR analysis of GDNF mRNA in astro-
cytes. The PCR products of the GDNF and GAPDH mRNAs 
had sizes of approximately 300 and 180 bp, respectively. 
GAPDH was used as the internal control. The GDNF mRNA 
level was increased in astrocytes treated with 10 µM of 
desipramine or fluoxetine. The experiments were repeated 
twice to reproduce the similar results. M, size marker. Dep., 
desipramine. Flx., fluoxetine.Page 2 of 5
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of NPCs in a contact-dependent manner.
In this study, we have examined the possibility that astro-
cytes are involved in antidepressant-induced proliferation
of NPCs. After treated with 10 µM of desipramine or
fluoxetine for 48 h, astrocytes were co-cultured with NPCs
in a contact-independent or contact-dependent manner.
In the former case, although naïve astrocytes induced the
proliferation of NPCs in comparison with NPCs that were
grown alone, desipramine or fluoxetine treatment of
astrocytes did not further increase the proliferation of
NPCs (Fig. 2). In addition, treatment with desipramine or
fluoxetine did not enhance the proliferation mediated by
astrocytes in a contact-dependent manner (Fig. 3). These
results, however, cannot exclude the possible involvement
of astrocytes in antidepressant-induced neurogenesis.
First, the response to antidepressants could be different
depending on the mouse strains. For example, C57BL/6
mice are less reactive to stressor and antidepressants than
BALB/c mice. These two strains show different 5-HT2C pre-
Effects of antidepressant-treated astrocytes on the prolifera-tion of NPCs in a contact-dep ndent cul ure syst mFigure 3
Effects of antidepressant-treated astrocytes on the 
proliferation of NPCs in a contact-dependent culture 
system. (A) Proliferation of NPCs co-cultured with astro-
cytes using an overlay co-culture system. After treating 
astrocytes with antidepressants, NPCs were overlaid on the 
astrocytes. NPCs were labeled with GFP using a retrovirus. 
After BrdU immunocytochemical analysis, the nuclei were 
stained with DAPI (blue). An arrowhead (pink) indicates 
BrdU and GFP double-positive NPCs, and the arrow (pink) 
shows BrdU-positive cells. These BrdU-only-positive cells 
represent astrocytes or NPCs that were not infected with 
the GFP-expressing retrovirus. Scale bar, 50 µm. (B) Quanti-
fication of the proliferation of NPCs. BrdU and GFP double-
positive cells were counted. In comparison with naïve astro-
cytes, those treated with 10 µM of desipramine or fluoxetine 
did not further increase the proliferation of NPCs. Data 
shown are mean values ± SEM. One-way ANOVA and 
Tukey's multiple comparison test were used for data analysis.
Effects of antidepressant-activated astrocytes on the prolifer-ation of NPCs in a contact-independent culture systemFigure 2
Effects of antidepressant-activated astrocytes on the 
proliferation of NPCs in a contact-independent cul-
ture system. (A) Proliferation of NPCs co-cultured with 
astrocytes using the Banker culture system. The astrocytes 
were not in contact with NPCs and could affect NPCs only 
through a diffusible factor. After BrdU immunocytochemical 
analysis, the nuclei were stained with DAPI (blue). An arrow-
head (pink color) marks BrdU-labeled NPCs. Scale bar, 50 
µm. (B) Quantification of the proliferation of NPCs. NPCs in 
control group were not exposed to astrocytes. In compari-
son with the control group, naïve astrocytes increased the 
number of BrdU (+) NPCs. However, in comparison with 
naïve astrocytes, those treated with 10 µM of desipramine or 
fluoxetine did not further increase the proliferation of NPCs 
(p > 0.05). Data shown are mean values ± SEM. One-way 
ANOVA was used for intergroup comparison, Tukey's multi-
ple comparison test was used for post-hoc comparisons.Page 3 of 5
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used the experimental scheme to treat BrdU for 24 h
because we hypothesized that antidepressants-activated
astrocytes might affect the proliferation of NPCs chroni-
cally. However, if antidepressants-activated astrocytes
affected the proliferation of NPCs transiently, we might be
unable to detect the significant effects. Finally, neurogen-
esis involves three developmental stages: proliferation,
differentiation of NPCs, and survival of immature or
mature neurons [19]. Although we did not observe the
antidepressant-induced proliferating effect of astrocytes,
the differentiation of NPCs or survival of immature or
mature neurons might be increased by neighboring astro-
cytes that had been activated by antidepressants. Moreo-
ver, a number of signals provided by the
microenvironment around the NPCs in the dentate gyrus
of the hippocampus have been known to regulate the
maintenance, proliferation and differentiation of NPCs
[19,20]. Thus, we cannot exclude a possibility that such
signals might be additionally required for the astrocyte-
induced proliferation of NPCs in the intact brain that had
been exposed to antidepressants.
Conclusion
We hypothesized that astrocytes might be involved in the
antidepressant-mediated neurogenesis since it was well
known that astrocytes induce the hippocampal neurogen-
esis and have serotonin or norepinephrine transporter
which are targets of the many antidepressants. However,
in both contact-dependent and contact-independent co-
culture system, astrocytes did not further increase the pro-
liferation of the hippocampal NPCs. Considering that
astrocytes are involved in many other neurological func-
tions, more investigations should be carefully performed
to elucidate the role of astrocytes on the antidepressant-
induced hippocampal neurogenesis.
Methods
Primary NPCs from the hippocampus of postnatal day 1
or 2 (P1 or P2) C57BL6/J mice were prepared essentially
as described previously [21,22]. Hippocampal tissue was
dissociated and plated on poly-L-lysine/laminin-coated
dishes (25 µg/ml poly-L-lysine; Sigma, 10 µg/ml laminin;
Invitrogen) in the presence of Dulbecco's modified Eagle's
medium/Nutrient mixture (DMEM/F12) (1:1) containing
B27 supplement (without vitamin A), 100 U/ml penicil-
lin, 100 µg/ml streptomycin, and 20 ng/ml bFGF (Gibco
BRL). Half of the medium was replaced with fresh
medium every 3 days. At least after DIV 6, NPCs were used
for co-culturing with astrocytes. For the overlay culture,
NPCs were infected with retrovirus to express GFP as a
marker at DIV 3.
Primary astrocytes from the hippocampus of P1 or P2
C57BL6/J mice were prepared as described previously
[21,22]. Hippocampal tissue was dissociated and plated
on a 25 cm2 tissue culture flask (SPL) in DMEM/F12 (1:1),
100 U/ml penicillin, 100 µg/ml streptomycin, and 10%
fetal bovine serum (FBS) (Gibco BRL). The medium was
replaced every 5 days. When the cells became confluent
(DIV 10–11), the flasks were shaken at 200 rpm and 37°C
for 3–4 h, and the medium was replaced with fresh
medium. Additionally, in case of the overlay co-culture,
the cells were treated with cytosine arabinoside (20 µM;
Sigma) for 72 h and then washed with phosphate buffered
saline (PBS) three times before co-culture.
For the Banker culture, astrocytes were passaged on the
poly-L-lysine-coated coverslips (20 µg/ml; Sigma) at a
density of 3.7 × 104/cm2. On the following day, the cells
were treated with 10 µM of fluoxetine (Sigma) or
desipramine (Sigma) dissolved in the culture medium for
48 h; this was followed by washing with PBS three times.
The concentration of each antidepressant was determined
on the basis of the steady-state brain concentrations esti-
mated from a clinical study [23]. With regard to the length
of time used for incubation with the antidepressants, we
treated the cells with the drugs for the longest possible
time, because only chronic antidepressant treatment, not
acute, is known to induce neurogenesis. However, the
treatment of cells with antidepressants longer than 48 h
induced cell death (data not shown) [24]. After washing
out the antidepressants, the astrocytes were co-cultured
with NPCs that were plated on the poly-L-lysine/laminin-
coated glass-bottom dish (10 µg/ml poly-L-lysine, 5 µg/
ml laminin) at a density of 1.5 × 104/cm2 in the N2
medium containing 20 ng/ml bFGF.
For the overlay culture, astrocytes were plated on the poly-
L-lysine-coated glass- bottom dish at a density of 3.8 ×
104/cm2. After one day, the cells were treated with 10 µM
of fluoxetine or desipramine for 48 h; this was followed
by three washes with PBS. After washing out the antide-
pressants, NPCs expressing GFP were overlaid onto astro-
cytes in the N2 medium containing 20 ng/ml bFGF.
Twenty-four hours after the co-culture, NPCs were treated
with BrdU (10 µM, Banker culture and 2.5 µM, overlay co-
culture, respectively) (Sigma) for 24 h. In case of the over-
lay co-culture, NPCs and astrocytes were treated with
BrdU. Finally, co-cultured NPCs were subjected to the
immunocytochemical analysis. Briefly, the cells were fixed
with 4% paraformaldehyde in PBS. For the detection of
BrdU, the cells were treated with 1 N HCl at 37°C for 30
min and then neutralized by washing with 0.1 M sodium
borate buffer. After the treatment with HCl, cells were
incubated with cold PBT (0.1% Triton X-100 and 0.1%
BSA in PBS) for 15 min. After blocking with a preblock
solution (2% BSA and 0.08% Triton X-100 in PBS) at
room temperature for 2 h, the cells were incubated over-Page 4 of 5
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solution: BrdU (1:100, mouse; Sigma), GFP (1:500, rab-
bit; Abcam), nestin (1:400, mouse; BD biosciences),
GFAP (1:400, rabbit; DAKO). After washing with PBT, the
cells were incubated with the fluorescence-labeled sec-
ondary antibodies for 2 h. Cells were counterstained for
15 min with 10 ng/ml 4', 6'-diamidino-2-phenylindole
(DAPI) (Molecular Probes) or 50 µg/ml propidium iodide
(PI). Immunofluorescence was visualized using a fluores-
cence microscope (Carl Zeiss). Fluorescence-positive cells
were quantified in 20 fields (×10) per dish either manu-
ally (overlay culture) or by using Image J software (Banker
culture).
Total RNA was collected using the TRIzol Reagent accord-
ing to the manufacturer's instructions (Invitrogen).
Reverse transcription (RT) reactions were performed using
SuperScript™ III Reverse Transcriptase (Invitrogen). cDNA
was synthesized from total RNA (2 µg) using a random
primer (0.1 µg). One microliter of the RT reaction product
was utilized as the template in the PCR with each of the
following primer sets. GAT ATT GCA GCG GTT CCT GT
and TTC GCA CTG TAG CAG GAA TG were used for
GDNF, while TGC ACC ACC AAC TGC TTA and GGA TGC
AGG GAT GAT GTT C were used for GAPDH. The number
of PCR cycles was set such that it was below saturation
conditions and was 30 and 23 for GDNF and GAPDH,
respectively.
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